Catheter Precision, Inc. Receives CE Mark for LockeT
Opens Multi-Billion Market Opportunity for the Company First Order for 100 Units…
New Study Reports Increased 4-Year Survival in Heart Transplant Patients when Utilizing the Paragonix SherpaPak System
Data from the GUARDIAN Registry, presented at the 45th ISHLT Annual Meeting,…
Positron Corporation Secures Agreement to Sell Four PET-CT Scanners
Niagara Falls, NY, April 14, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron”…
Lupin Digital Health Introduces Comprehensive Post-Procedure Home-Based Care Guide in Collaboration with the American College of Cardiology
An initiative aimed at improving patient recovery and well-being following cardiac procedures…
Elutia Advances Scientific Leadership with Publication of New Study on Antibiotic-Eluting Biologic Envelope
March 25, 2025 16:05 ET | Source: Elutia Inc. — Rigorous testing…
Can-Fite Innovative Publication: Namodenoson in Liver Cancer Treatment Alongside with Cardiac, Liver, and Neurological Benefits
March 03, 2025 06:00 ET | Source: Can-Fite BioPharma Ltd. Unlike chemotherapy…
Positron Corporation Secures Agreement for Three NeuSight PET-CT 64 Slice Scanners
Niagara Falls, NY, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (OTC:…
Volta Medical Artificial Intelligence-guided Cardiac Ablation Procedure Improves Treatment of Atrial Fibrillation
February 14, 2025 05:30 ET | Source: Volta Medical AI-Guided Cardiac Ablation…
Solid Biosciences Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreichs Ataxia
- SGT-212 is the only full-length frataxin replacement gene therapy candidate targeting…
Continuous Biomarker Monitoring Pioneer Proton Intelligence Inc Announces a $6.95 Million Seed Raise to Initiate Human Trials for Potassium Monitoring in Patients With Kidney Disease
VANCOUVER, British Columbia & MELBOURNE, Australia--(BUSINESS WIRE)--Proton Intelligence Inc., developing the first-ever…